Early research (Phase 1)Study completedNCT02065973
What this trial is testing
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101
Who this might be right for
High-risk HPV Infection and Biopsy-proven CIN1
PDS Biotechnology Corp. 12